BMRN vs LULU · P/E 40, rev $1.76B vs P/E 17, rev $11.10B
Biomarin Pharmaceutical Inc (BMRN) versus Lululemon Athletica Inc. (LULU) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Lululemon Athletica Inc. (LULU) is a apparel retail company listed on US. It is led by Calvin McDonald.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported LULU revenue for 2026-02-01 was $11.10B. Net income was $1.58B. Revenue was up 4.9% from 2025-02-02 to 2026-02-01. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
Not investment advice. Open the BMRN and LULU stock pages for the full models.
Not investment advice.